IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

SCRIFFIGNANO, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.000
EU - Europa 2.251
AS - Asia 895
SA - Sud America 233
AF - Africa 179
Continente sconosciuto - Info sul continente non disponibili 87
OC - Oceania 2
Totale 6.647
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.872
RU - Federazione Russa 1.185
SG - Singapore 373
IE - Irlanda 326
CN - Cina 200
BR - Brasile 176
IT - Italia 170
CI - Costa d'Avorio 128
FR - Francia 105
DE - Germania 95
GB - Regno Unito 79
FI - Finlandia 78
VN - Vietnam 68
UA - Ucraina 59
HK - Hong Kong 55
CA - Canada 53
BD - Bangladesh 45
IN - India 38
SE - Svezia 32
AT - Austria 28
ZA - Sudafrica 20
AR - Argentina 19
PL - Polonia 18
BE - Belgio 16
NL - Olanda 16
IQ - Iraq 14
LT - Lituania 14
ID - Indonesia 12
JP - Giappone 12
MX - Messico 12
ES - Italia 11
IL - Israele 11
MY - Malesia 11
SC - Seychelles 11
TR - Turchia 10
CO - Colombia 9
SV - El Salvador 9
VE - Venezuela 9
GT - Guatemala 8
TT - Trinidad e Tobago 8
CL - Cile 7
CR - Costa Rica 7
HN - Honduras 7
JM - Giamaica 7
UZ - Uzbekistan 7
EC - Ecuador 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
NI - Nicaragua 5
PK - Pakistan 5
BO - Bolivia 4
JO - Giordania 4
KE - Kenya 4
MA - Marocco 4
AZ - Azerbaigian 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
GP - Guadalupe 3
PR - Porto Rico 3
TH - Thailandia 3
AL - Albania 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
BB - Barbados 1
BG - Bulgaria 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
IR - Iran 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 6.563
Salva come PNG Salva come JPEG
Città #
Dallas 541
San Jose 367
Moscow 366
Dublin 326
Ashburn 214
Singapore 200
Chandler 184
Abidjan 128
Jacksonville 113
Council Bluffs 78
Helsinki 76
Beijing 75
The Dalles 69
Hong Kong 54
Los Angeles 54
Santa Clara 47
Ann Arbor 45
Lauterbourg 44
Milan 39
Frankfurt am Main 37
New York 36
Princeton 29
North Bergen 27
Rome 27
Ho Chi Minh City 26
Vienna 26
Orem 25
Wilmington 24
San Mateo 23
Charlestown 22
Columbus 20
São Paulo 20
Boardman 19
Dearborn 19
Denver 17
Phoenix 16
Brooklyn 15
Brussels 15
Chennai 15
Hanoi 15
Montreal 15
San Francisco 15
London 14
Amsterdam 13
Atlanta 13
Naples 13
Grover Beach 12
Johannesburg 12
Manchester 12
Toronto 12
Warsaw 12
Redwood City 11
Seattle 11
Tokyo 11
Chicago 10
Miano 9
Rio de Janeiro 9
San Salvador 9
Janesville 8
Newark 8
Woodbridge 8
Houston 7
Nanjing 7
Ottawa 7
Poplar 7
Boston 6
Fortaleza 6
Guangzhou 6
Hillsboro 6
Kingston 6
San José 6
Shanghai 6
Tashkent 6
Buffalo 5
Dhaka 5
Esslingen am Neckar 5
Falkenstein 5
Guatemala City 5
Kirkland 5
Managua 5
Mexico City 5
Stockholm 5
Washington 5
Baghdad 4
Fleet 4
Istanbul 4
Jakarta 4
Nairobi 4
New Delhi 4
Philadelphia 4
Plymouth Meeting 4
Wroclaw 4
Amman 3
Ariccia 3
Belo Horizonte 3
Borås 3
Brasília 3
Buenos Aires 3
Campobasso 3
Cape Town 3
Totale 3.916
Salva come PNG Salva come JPEG
Nome #
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 231
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 222
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 202
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 193
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 185
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab 182
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 165
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 165
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 162
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 161
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 161
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 153
Non-steroidal anti-inflammatory drugs in psoriatic arthritis: clinical practice suggestions based on scientific evidence and expert opinion 152
Dr. Lubrano, et al reply 151
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 149
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 149
A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis 147
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 147
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 145
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 143
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 142
Role of comorbidities in spondyloarthritis including psoriatic arthritis 141
Difficult-to-treat concept in Psoriatic Arthritis: analysis of two potential definitions in a large group of patients. A cross-sectional study 139
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report 122
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 118
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? 117
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis 117
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 113
Psoriatic Arthritis in Males and Females: Differences and Similarities 110
Residual disease activity and associated factors in Psoriatic Arthritis 110
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study 108
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 105
Il laboratorio in Reumatologia 104
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis 102
Rheumatology Care in the Face of COVID-19 98
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients 97
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? 95
Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review 93
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective 93
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 91
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis 91
The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease 90
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 89
Women in rheumatology: major contributions and key discoveries of the twentieth century 86
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 85
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study 84
Triple jump for the optimal management of psoriatic arthritis: Diet, sleep and exercise - A review 83
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review 76
Patient reported outcomes in early vs late diagnosis of psoriatic arthritis|Resultados informados por los pacientes en el diagnóstico precoz respecto a los pacientes con diagnóstico tardío en la artritis psoriásica 74
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 68
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 62
Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study 50
Composite Disease Activity Indices Tailored for Psoriatic Arthritis: A Review 37
PET imaging in the psoriasis and psoriatic arthritis field: un update 37
Abatacept for the treatment of psoriatic arthritis 30
Potential Differences in Clinical Features, Disease Activity, Function and Impact of Disease Between Oligo and Polyarticular Psoriatic Arthritis 25
Totale 6.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 0 0 4 0 2 11 21 32 2 11
2022/2023752 88 30 16 58 18 50 8 40 379 37 19 9
2023/2024243 59 40 24 5 12 13 2 21 9 13 15 30
2024/2025878 152 36 102 13 150 21 14 41 98 37 97 117
2025/20263.350 116 263 413 209 758 609 335 133 155 265 50 44
2026/2027884 93 102 238 419 32 0 0 0 0 0 0 0
Totale 6.647